Working… Menu

Olaparib, Cediranib Maleate, and Standard Chemotherapy in Treating Patients With Small Cell Lung Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02899728
Recruitment Status : Suspended (Other - Pending protocol amendment Other - Pending response to FDA comments.)
First Posted : September 14, 2016
Last Update Posted : October 8, 2019
Information provided by (Responsible Party):
National Cancer Institute (NCI)

No Study Results Posted on for this Study
Recruitment Status : Suspended
Estimated Primary Completion Date : April 7, 2020
Estimated Study Completion Date : April 7, 2020